Cost analysis study of different brands of commonly used drugs for bronchial asthma available in india -A pharmacoeconomics study
Journal Title: Indian Journal of Pharmacy and Pharmacology - Year 2017, Vol 4, Issue 4
Abstract
Introduction: To evaluate the price variation of various brands of antiasthmatic drugs available in single and in combination. Materials and Methods: An observational study was carriedoutusing ‘CIMS’ &‘IDR’ (July-Oct 2016), where in the difference in the maximum and minimum price of a particular drug beingmanufactured by differentpharmaceutical companies, in the same strength, number and dosage formwas compared and the percentage variation in price was calculated. Data is analysed using descriptive statistical formula. Results: In single drug therapy, among bronchodilator, β2 sympathomimetic: salbutamol (4mg) andsalbutamol (20µg) shows maximum and minimum price variation of 333.5% and1.47%. Among Leukotriene antagonists, montelukast (5mg tab) shows maximum of 185% and minimum of 0.539% as chewable tablet. Mast cell stabilizer ketotifen (1mg) shows maximum of 195.23% and minimum 142.307% as syrup. Among systemic corticosteroids methylprednisolone showed maximum and minimum of 701.01% and 4.16% 4mg and 2mg dosages. Inhalational steroids budesonide (0.5mg/ml) shows maximum of 486.5% and fluticasone propionate (50µg) shows minimum of 0.41%. In combination therapy salbutamol with theophylline shows a maximum of 900% and terbutaline, ambroxol hydrochloride with guaiphenesin shows minimum of 0.71% while Inhalational steroids maximum of 80.06% with fluticasone(100µg), formoterol fumarate(6µg) combination and minimum of 0.37% with budesonide(40µg) and formoterol fumarate(6µg). Conclusion: The percentage price variation of different brands of the same drug and dosage manufactured in India for treatment of bronchial asthma is substantially wide. The pricing should be considered in view of better compliance. The clinicians should be aware of these price variations to reduce the economic burden of drug therapy.
Authors and Affiliations
Dharani Devangi, Shashirekha C. H2, Shruthi S L
Keywords
Related Articles
- EP ID EP295777
- DOI 10.18231/2393-9087.2017.0038
- Views 86
- Downloads 0
Anti-inflammatory studies on a saponin albichinoside
Introduction Pain and inflammation are a day to day affliction for all living beings Mankind has for years been trying to relieve the agony of pain inflammation through various means with a large amount of success Still...
Evaluation of Efficacy of Nevirapine Regimen versus Efavirenz Regimen
Introduction: CD4 count can be used as marker to assess the effectiveness of antiretro viral treatment (ART), mortality and survival rates in HIV patients. It is an important guide to treatment as it reflects drug resist...
Knowledge, attitude & perceptions of 3rd term medical students towards clinical trials in a medical college in southern India
Aim of the study: The present Study was performed to know the awareness of clinical trials and to assess the effectiveness of an educational intervention. Materials and Method: This was a questionnaire-based pre- and pos...
A prospective observational study of drug usage in paediatric inpatients at district teaching hospital
Introduction: Aim of our study was to observe and analyse the prescribing pattern of drugs in hospitalised patients of paediatric department. Materials and Methods: A prospective observational study was conducted over a...
Cost analysis of antifungal drugs available in India: A pharmacoeconomic perspective
Introduction: Fungal infections are common and treatment imposes economic burden on the patients. The compliance of the patient may be significantly dependent on the cost of the prescribed medicines, especially in develo...